Subsequently somatic mutations in calreticulin (CALR), a chaperone protein with known functions in regulating protein folding and cellular calcium metabolism, were detected in 67 % of the ET and 88 % of the PMF patients that were negative for the JAK2 and MPL mutations (Fig. 1) [26]. The gene discussed is JAK2; the disease is essential thrombocythemia.